Correlation Between Bionoid Pharma and Antisense Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bionoid Pharma and Antisense Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bionoid Pharma and Antisense Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bionoid Pharma and Antisense Therapeutics Limited, you can compare the effects of market volatilities on Bionoid Pharma and Antisense Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bionoid Pharma with a short position of Antisense Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bionoid Pharma and Antisense Therapeutics.

Diversification Opportunities for Bionoid Pharma and Antisense Therapeutics

-0.13
  Correlation Coefficient

Good diversification

The 3 months correlation between Bionoid and Antisense is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Bionoid Pharma and Antisense Therapeutics Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Antisense Therapeutics and Bionoid Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bionoid Pharma are associated (or correlated) with Antisense Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Antisense Therapeutics has no effect on the direction of Bionoid Pharma i.e., Bionoid Pharma and Antisense Therapeutics go up and down completely randomly.

Pair Corralation between Bionoid Pharma and Antisense Therapeutics

Given the investment horizon of 90 days Bionoid Pharma is expected to generate 5.16 times more return on investment than Antisense Therapeutics. However, Bionoid Pharma is 5.16 times more volatile than Antisense Therapeutics Limited. It trades about 0.08 of its potential returns per unit of risk. Antisense Therapeutics Limited is currently generating about -0.31 per unit of risk. If you would invest  25.00  in Bionoid Pharma on August 25, 2024 and sell it today you would lose (5.00) from holding Bionoid Pharma or give up 20.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Bionoid Pharma  vs.  Antisense Therapeutics Limited

 Performance 
       Timeline  
Bionoid Pharma 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Bionoid Pharma are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively uncertain basic indicators, Bionoid Pharma reported solid returns over the last few months and may actually be approaching a breakup point.
Antisense Therapeutics 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Antisense Therapeutics Limited are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain forward-looking indicators, Antisense Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Bionoid Pharma and Antisense Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bionoid Pharma and Antisense Therapeutics

The main advantage of trading using opposite Bionoid Pharma and Antisense Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bionoid Pharma position performs unexpectedly, Antisense Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Antisense Therapeutics will offset losses from the drop in Antisense Therapeutics' long position.
The idea behind Bionoid Pharma and Antisense Therapeutics Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets